TMCnet News

Cartiva to Present at 13th Annual Canaccord Genuity Musculoskeletal Conference
[February 22, 2018]

Cartiva to Present at 13th Annual Canaccord Genuity Musculoskeletal Conference


Cartiva, Inc., a medical device company focused on the treatment of osteoarthritis of the extremities, today announced that Tim Patrick, President and Chief Executive Officer, will present at the 13th Annual Canaccord Genuity Musculoskeletal Conference in New Orleans. Mr. Patrick is scheduled to present at 10:00 a.m. CST on Tuesday, March 6, 2018.

About Cartiva, Inc.

Based in Alpharetta, Ga., Cartiva, Inc. is a medical device company focused on the treatment of oseoarthritis of the extremities. Cartiva's synthetic cartilage is the only FDA-approved biomedical implant that mimics natural cartilage. The company's venture investors include New Enterprise Associates and Windham Venture Partners. Additional information is available on the company's website at www.cartiva.net.





[ Back To TMCnet.com's Homepage ]